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INTRODUCTION:  We  herein  report  an  extremely  rare case  of  a liposarcoma  developing  in the  ischiorectal
fossa  that  was  completely  resected  using  a transsacral  approach.
PRESENTATION OF  CASE:  A 74-year-old  man  was  admitted  to  our  institute  because  of  a large  perianal
tumor.  A  pelvic  magnetic  resonance  imaging  (MRI)  revealed  an  8 cm  × 7  cm  ×  5  cm sized  encapsulated
heterogeneous  tumor  on the  right  side  of  the  ischiorectal  fossa.  Transsacral  excision  was  performed
under  a  diagnosis  of liposarcoma.  The  tumor  was  partially  ﬁxed  to  the  external  sphincter  and  pub-
orectalis.  Therefore,  the  muscles  were  partially  resected  to ensure  sufﬁcient  margins.  Histopathological
examination  revealed  a well  differentiated  liposarcoma  and  negative  surgical  margins.schiorectal fossa
oft  tissue tumor
DISCUSSION: The  basic  treatment  strategy  of  liposarcoma  is  surgical  resection,  whereas  the  effects  of
chemotherapy  or radiotherapy  remain  limited.  Although  no postoperative  adjuvant  therapy  has  been
performed  in  our  case,  no  recurrences  have  occurred  for 1 year  after  surgery.
CONCLUSION: Although  the  curative  resection  of large  tumors  located  in the  ischiorectal  fossa  is  usually
difﬁcult,  the  complete  resection  of  liposarcoma  is  the  main  potentially  curative  treatment.  A  transsacral
approach  is  useful  for a complete  resection.
gical © 2012 Sur
. INTRODUCTION
Liposarcoma is one of the most common types of soft tissue sar-
oma. The basic treatment strategy is surgical resection, whereas
he effects of chemotherapy or radiotherapy remain limited. We
erein report an extremely rare case of a liposarcoma develop-
ng in the ischiorectal fossa that was completely resected using a
ranssacral approach.
.  PRESENTATION OF CASE
A 74-year-old man  had noticed a perianal lump with a 5-year
istory that had recently increased in size, with no symptoms
ffecting bowel habits. On a physical examination, an elastic soft
ass located on the right side of the perianus with a protuberance
Fig. 1) pushing the anal canal and lower rectum, without any pain
r tenderness, was noted. Magnetic resonance imaging (MRI) and
omputed tomographic (CT) scans were performed for a differential
iagnosis and to assess the extent of tumor involvement. The pelvic
RI  scan showed a well-deﬁned tumor (8 cm × 7 cm × 5 cm)  with
 heterogeneously contrasted appearance in the right ischiorectal
∗ Corresponding author at: Department of Surgery, Keio University School of
edicine, 35 Shinano-machi, Shinjuku-ku, Tokyo 160-8582, Japan.
el.: +81 3 3353 1211; fax: +81 3 3355 4707.
E-mail address: seishima@a3.keio.jp (R. Seishima).
210-2612     © 2012 Surgical Associates Ltd. Published by Elsevier Ltd.  
ttp://dx.doi.org/10.1016/j.ijscr.2012.09.011
Open access under CCAssociates Ltd. Published by Elsevier Ltd. 
fossa below the levator plane (Fig. 2a and b). The tumor was adja-
cent to the anal canal and lower rectum, but no clear invasion of
the adjacent tissues, such as the external sphincter or puborectalis,
was seen. A chest to pelvic CT scan showed no other local or distant
lesions. The ﬁrst choice for the differential diagnosis was  a liposar-
coma, which was  considered to be surgically resectable with or
without the excision of the adjacent tissues.
The patient was  placed jack knife position on the operating table
under general anesthesia and a transsacral approach was selected
for the resection of the tumor. We  made an incision 2 cm distant
from the right edge of lower sacrum and coccyx (Fig. 1). We  tran-
sected the muscle ﬁbers of the gluterus maximus on the lateral side
around the tumor. On the medial side, ﬁbers of the external anal
sphincter were visualized. Superiorly, the surface of the lower half
of the sacrum was  exposed down to the coccyx. We did not resect
the coccyx. The lateral and upper margins of the tumor were com-
pletely divided from the adjacent tissues: however, medial margin
was unclear and ﬁxed to the external sphincter and puborectalis.
To ensure a sufﬁcient distance from the tumor margin, the exter-
nal sphincter and puborectalis muscles were partially excised and
the resulting defects were repaired with an appropriate anal tonus.
The patient has not experienced any postoperative morbidities or
difﬁculties with his bowel habits and was  discharged 7 days after
Open access under CC BY-NC-ND license.the surgery.
A  pathological examination revealed the complete resection of
a well-differentiated liposarcoma, which had lipocytes with dense
atypical nuclei (Fig. 3).
 BY-NC-ND license.
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Fig. 1. Aspect of the large perianal tumor. The mass located in the right side of
perianus  with protuberance. The incision line is described by a black line.
Fig. 2. MRI imagings of the tumor and after surgery. (a) Axial T1 weighted image of MRI  sh
T2  weighted image of MRI showed that the tumor was  adjacent to the anal canal and lowe
and puborectalis. (c) Axial T1 weighted and (d) sagital T2 weighted image of MRI, showed
Fig. 3. Histopathological ﬁndings of the tumor. (a) Hyperplasia of variable-sized lipocyte
nuclei are seen in various lipocytes (hematoxylin and eosin staining, ×40).PEN  ACCESS
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No recurrences have occurred within 1 year after surgery (Fig. 2c
and d), and no postoperative therapy has been performed.
3.  DISCUSSION
Among more than 50 histological types of soft tissue sar-
coma, the most common subtype is liposarcoma, accounting for
24% of sarcomas in extremities and 45% of sarcomas in the
retroperitoneum.1 The present case was  an extremely rare liposar-
coma that developed in the ischiorectal fossa; to the best of our
knowledge, there are only few reports of such liposarcomas have
been made.2 Liposarcoma is pathologically classiﬁed into 5 types
(well-differentiated, myxoid, pleomorphic, round cell, and mixed).
The histologic subtype (as well as the tumor location) is a pre-
dictor of patient outcome. Pleomorphic type, round cell type, and
mixed type are high-grade liposarcomas, which are aggressive
owed a well-deﬁned tumor with a heterogeneously contrasted content. (b) Sagital
r rectum, but not clearly invasive to the adjacent tissues such as external sphincter
 no clear evidence of recurrence after surgery.
s with ﬁbrosis are seen (hematoxylin and eosin staining, ×10). (b) Dense atypical
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umors with metastatic potential; meanwhile, well-differentiated
nd myxoid type liposarcomas are low-grade liposarcomas that
ollow a more indolent clinical course.3
The current therapy for liposarcoma follows the guidelines
stablished for the treatment of soft tissue sarcomas and heavily
elies on the achievement of complete surgical extirpation.4 Com-
lete resection is strongly associated with a favorable outcome.
herefore, an aggressive approach, such as en bloc resection with
djacent organs, is generally selected depending on the conditions
f individual patients. Although a 1–2 cm distance from the tumor
argin is widely accepted to be adequate, no studies have sug-
ested the superiority of larger margins in negative cases. At the
inimum, a macroscopically negative margin is essential for a good
rognosis after surgical treatment.
Another treatment available for soft tissue sarcoma is
hemotherapy, generally using anthracyclines (doxorubicin and
pirubicin) and ifosfamide. However, no clear evidence of the pos-
tive effects of postoperative adjuvant therapy on the relapse-free
nd overall survival rates is available.5 The European Organiza-
ion for Research and Treatment of Cancer (EORTC) Soft Tissue
nd Bone Sarcoma Group retrospectively evaluated the effects of
oxorubicin versus ifosfamide-based regimens for patients with
dvanced soft tissue sarcoma. The results of this study indi-
ated that ifosfamide-based therapies may  be less beneﬁcial in
iposarcoma patients compared with doxorubicin monotherapy.6
 pivotal meta-analysis from the Sarcoma Meta-Analysis Col-
aboration (SMAC) published in 1997 showed that postoperative
oxorubicin adjuvant chemotherapy improved local control and
elapse free survival rates, but not the overall survival rate, com-
ared with surgery alone.5
Although radiation therapy has been reported to enhance the
ocal control rate, compared with surgery alone, in some circum-
tances, this modality did not lead to an improvement in the overall
urvival rate.7,8 Accordingly, radiation therapy is especially applica-
le for intermediate or high-grade soft tissue sarcomas to minimize
he extent of local surgical resection required. The advantages of
re- or post-operative radiation therapy remain unclear for local
ontrol.9 However, preoperative radiation therapy is associated
ith a high incidence of wound complications, while postopera-
ive radiation therapy is associated with an increased rate of ﬁbrosis
r edema. Therefore, radiation therapy must be performed on an
ndividual patient basis.
Taking these matters into consideration, we decided to care-
ully observe this patient, who had a low-grade histological
ype of well-differentiated liposarcoma and negative surgi-
al margins, without performing any postoperative adjuvant
herapies.
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4. CONCLUSION
The main potentially curative treatment of liposarcoma is the
complete resection. A transsacral approach is useful for a complete
resection for large tumors located in the ischiorectal fossa.
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